CRP and cancer: A number of related parameters have been evaluated as potential biomarkers of systemic inflammation in patients with cancer, including C-reactive protein (CRP), lactate dehydrogenase (LDH), circulating white blood cells (WBC), absolute neutrophil count (ANC), neutrophil-to-lymphocyte ratio (NLR) and derived NLR [dNLR; ANC/(WBC concentration−ANC)].17